Dare Bioscience
DARE
22 hedge funds and large institutions have $2.08M invested in Dare Bioscience in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 11 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
136% more capital inflows, than outflows
Capital inflows: $294K | Capital outflows: $124K
0.53% more ownership
Funds ownership: 7.14% → 7.67% (+0.53%)
21% less funds holding
Funds holding: 28 → 22 (-6)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AMH Equity
Great Neck,
New York
|
+$78.7K |
| 2 |
Advisory Services Network
Atlanta,
Georgia
|
+$47K |
| 3 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$46.7K |
| 4 |
Founders Financial Securities
Towson,
Maryland
|
+$39.6K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$35.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Securities
New York
|
-$34.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$25.2K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11.7K |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$10.4K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$10.3K |
DARE Hedge Fund Activity: Q3 2024 in Review
22 of the 6,989 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q3 2024, worth a combined $2.08M — down 15% from $2.46M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of DARE and 5 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 10 added.
The largest buyer was AMH Equity, adding an estimated $78.7K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $34.6K sold.
- 22 institutional investors held Dare Bioscience (DARE) as of Q3 2024, down from 28 in Q2 2024.
- Funds reported $2.08M of Dare Bioscience stock for Q3 2024, down 15% quarter-over-quarter.
- 5 funds opened new Dare Bioscience positions in Q3 2024 and 11 closed out, a net change of -6 holders.
- The largest Dare Bioscience buyer in Q3 2024 was AMH Equity, an estimated $78.7K added.
- The largest Dare Bioscience seller in Q3 2024 was Two Sigma Securities, an estimated $34.6K sold.
Based on aggregated 13F filings for Q3 2024.